NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/12/2024
Back to search
Official data from USPTO
G
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
11/12/2024
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
10/26/2023
Registration date
11/12/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/12/2024
Last transaction
11/12/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
03
Owner location
Mechelen, BE
Examiner
HELLMAN, ELI J
Law office
L20
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the letter "G" in white superimposed on a square field filled with the gradient composed of orange, teal, and turquoise.
Holders and representatives
Holders
Galapagos NV
Representatives
Alexandra MacKay STITES & HARBISON PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint diseaseautoinflammation diseasesautoimmune diseasesproliferative diseasesendocrine diseasesmetabolic diseasesskin diseaseslung diseasesfibrotic diseasescardiovascular diseasespainhepatitis B viruskidney diseasesosteoporosisosteoarthritisrheumatoid arthritisatopic dermatitisidiopathic pulmonary fibrosisinflammatory bowel diseaseCrohn's diseaseulcerative colitisankylosing spondylitispsoriatic arthritisSjogren's syndromelupusuveitissclerodermanon-alcoholic steatohepatitispolycystic kidney diseasetype 2 diabetes; Biopharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint diseaseautoinflammation diseasesautoimmune diseasesproliferative diseasesendocrine diseasesmetabolic diseasesskin diseaseslung diseasesfibrotic diseasescardiovascular diseasespainhepatitis B viruskidney diseasesosteoporosisosteoarthritisrheumatoid arthritisatopic dermatitisidiopathic pulmonary fibrosisinflammatory bowel diseaseCrohn's diseaseulcerative colitisankylosing spondylitispsoriatic arthritisSjogren's syndromelupusuveitissclerodermanon-alcoholic steatohepatitispolycystic kidney diseasetype 2 diabetes
Class 42
Medicalscientific and industrial research services; industrial research in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development services; scientific and medical research services in the nature of examining and testing of genes; pharmaceutical and biopharmaceutical drug development services featuring the examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; pharmaceutical drug development services featuring the examination and testing of medicaments; product research and development in the field of test systems for pharmaceutical and biopharmaceutical products; database development servicesnamely configuration and customization of computer databases containing information regarding medicalpharmaceutical and biopharmaceutical information; Pharmaceutical drug development services
Class 44
Medical services; providing medical and pharmaceutical advice; gene bank services
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/27/2024
PUBO
PUBLISHED FOR OPPOSITION
08/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/22/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/13/2024
GNRT
NON-FINAL ACTION E-MAILED
06/13/2024
CNRT
NON-FINAL ACTION WRITTEN
06/13/2024
DOCK
ASSIGNED TO EXAMINER
06/09/2024
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/01/2023
NWAP
NEW APPLICATION ENTERED
10/30/2023
Continuous trademark protection
Get notified about every new filing that threatens G or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.